XML 19 R7.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Cumulative effect of accounting changes
Common Stock
Additional Paid-in Capital
Deferred Stock Units
Retained Earnings
Retained Earnings
Cumulative effect of accounting changes
Accumulated Other Comprehensive (Loss) Income
Treasury Stock
Noncontrolling Interest
Balance beginning of period (in shares) at Dec. 31, 2019     105,711              
Balance beginning of period at Dec. 31, 2019 $ 177,825 $ (1,829) $ 10,571 $ 1,213,517 $ 4,462 $ 1,595,648 $ (1,829) $ (46,182) $ (2,600,543) $ 352
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income 111,856         111,827       29
Other comprehensive income (loss), net (9,064)             (9,064)    
Repurchases of common stock (187,767)               (187,767)  
Common stock issued under stock plans (in shares)     203              
Common stock issued under stock plans 9,750   $ 20 9,730            
Share-based compensation cost 7,284     7,238 46          
Balance end of period (in shares) at Mar. 31, 2020     105,914              
Balance end of period at Mar. 31, 2020 108,055   $ 10,591 1,230,485 4,508 1,705,646   (55,246) (2,788,310) 381
Balance beginning of period (in shares) at Dec. 31, 2019     105,711              
Balance beginning of period at Dec. 31, 2019 177,825 $ (1,829) $ 10,571 1,213,517 4,462 1,595,648 $ (1,829) (46,182) (2,600,543) 352
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income 260,852                  
Other comprehensive income (loss), net (10,850)                  
Balance end of period (in shares) at Jun. 30, 2020     106,031              
Balance end of period at Jun. 30, 2020 273,400   $ 10,603 1,247,456 5,402 1,854,586   (57,032) (2,788,052) 437
Balance beginning of period (in shares) at Mar. 31, 2020     105,914              
Balance beginning of period at Mar. 31, 2020 108,055   $ 10,591 1,230,485 4,508 1,705,646   (55,246) (2,788,310) 381
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income 148,996         148,940       56
Other comprehensive income (loss), net (1,786)             (1,786)    
Issuance of common stock 258               258  
Common stock issued under stock plans (in shares)     117              
Common stock issued under stock plans 10,080   $ 12 10,068 0          
Deferred stock units activity 0     (894) 894          
Share-based compensation cost 7,797     7,797 0          
Balance end of period (in shares) at Jun. 30, 2020     106,031              
Balance end of period at Jun. 30, 2020 $ 273,400   $ 10,603 1,247,456 5,402 1,854,586   (57,032) (2,788,052) 437
Balance beginning of period (in shares) at Dec. 31, 2020 106,457   106,457              
Balance beginning of period at Dec. 31, 2020 $ 632,795   $ 10,646 1,294,849 4,503 2,175,595   (53,615) (2,799,890) 707
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income 204,289         204,257       32
Other comprehensive income (loss), net (5,921)             (5,921)    
Repurchases of common stock (154,033)               (154,033)  
Common stock issued under stock plans (in shares)     219              
Common stock issued under stock plans 17,430   $ 22 17,408            
Share-based compensation cost 8,875     8,829 46          
Balance end of period (in shares) at Mar. 31, 2021     106,676              
Balance end of period at Mar. 31, 2021 $ 703,435   $ 10,668 1,321,086 4,549 2,379,852   (59,536) (2,953,923) 739
Balance beginning of period (in shares) at Dec. 31, 2020 106,457   106,457              
Balance beginning of period at Dec. 31, 2020 $ 632,795   $ 10,646 1,294,849 4,503 2,175,595   (53,615) (2,799,890) 707
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income 406,895                  
Other comprehensive income (loss), net $ 5,224                  
Balance end of period (in shares) at Jun. 30, 2021 106,748   106,748              
Balance end of period at Jun. 30, 2021 $ 748,223   $ 10,675 1,339,413 5,630 2,582,434   (48,391) (3,142,301) 763
Balance beginning of period (in shares) at Mar. 31, 2021     106,676              
Balance beginning of period at Mar. 31, 2021 703,435   $ 10,668 1,321,086 4,549 2,379,852   (59,536) (2,953,923) 739
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income 202,606         202,582       24
Other comprehensive income (loss), net 11,145             11,145    
Repurchases of common stock (188,378)               (188,378)  
Common stock issued under stock plans (in shares)     72              
Common stock issued under stock plans 9,778   $ 7 9,771            
Deferred stock units activity 0     (1,035) 1,035          
Share-based compensation cost $ 9,637     9,591 46          
Balance end of period (in shares) at Jun. 30, 2021 106,748   106,748              
Balance end of period at Jun. 30, 2021 $ 748,223   $ 10,675 $ 1,339,413 $ 5,630 $ 2,582,434   $ (48,391) $ (3,142,301) $ 763